Mereo BioPharma Group plc

MREO · NASDAQ
Analyze with AI
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Assets
Cash & Equivalents$69,802$57,421$68,182$126,749
Short-Term Investments$0$0$0$769
Receivables$3,250$3,732$0$0
Inventory$0$0$0$0
Other Curr. Assets$1,711$2,607$7,015$6,798
Total Curr. Assets$74,763$63,760$75,197$134,316
Property Plant & Equip (Net)$984$1,650$2,216$3,421
Goodwill$0$0$0$0
Intangibles$643$1,089$0$33,218
Long-Term Investments$0$0$0$0
Tax Assets$0$0$0$0
Other NC Assets$0$0$0$0
Total NC Assets$1,627$2,739$2,216$36,640
Other Assets$0$0$0$0
Total Assets$76,390$66,499$77,413$170,956
Liabilities
Payables$2,440$2,346$3,492$3,090
Short-Term Debt$6,242$652$13,890$841
Tax Payable$770$662$0$0
Deferred Revenue$0$0$0$0
Other Curr. Liab.$4,396$5,826$6,993$13,028
Total Curr. Liab.$13,848$9,486$24,375$16,959
LT Debt$187$5,300$1,479$21,824
Deferred Rev, NC$0$0$0$0
Deferred Tax Liab, NC$0$0$0$0
Other NC Liab.$1,386$1,176$157$13,166
Total NC Liab.$1,573$6,476$1,636$34,990
Other Liabilities$0$0$0$0
Cap. Leases$894$1,558$2,043$3,213
Total Liabilities$15,421$15,962$26,011$51,949
Equity
Pref Stock$0$0$0$0
Common Stock$3,059$2,775$2,478$2,373
Retained Earnings-$462,883-$419,630-$404,575-$401,596
AOCI-$18,849-$17,485-$21,687$183,584
Other Equity$539,642$484,877$475,186$334,645
Total Equity$60,969$50,537$51,402$119,007
Supplemental Information
Minority Interest$0$0$0$0
Total Liab. & Tot. Equity$76,390$66,499$77,413$170,956
Net Debt-$63,373-$51,469-$52,813-$104,084
Mereo BioPharma Group plc (MREO) Financial Statements & Key Stats | AlphaPilot